📈 Technical Chart Patterns & Trend Analysis 📉
Identifying potential trading opportunities based on trend analysis:
bullish divergence can be seen oh daily time frame and aslo a double bottom indicating a trend reversal. BUY STOP will be good option in this scenario .
📊 Technical analysis helps identify potential entry and exit points for trades. Remember to use...
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of...
AYTU Aytu BioPharma announced today that the FDA has granted Fast Track designation to AR101, a protein kinase inhibitor, for the treatment of patients with Vascular Ehlers-Danlos Syndrome.
After the bullish news, AYTU stock hit the all time low level.
52 Week Range 0.76 - 7.20
LADENBURG THALM has a price target of $14.50 for the stock.
I think a reversal is...
What happened here?!
The fib potential is perhaps the biggest I have ever seen.
The 0.236 (usually easy to hit) is way above there with a modest 11652x
Fib top is an insane 393316x from its current price
Imagine if a few million crayon eaters find this one day.
The most bearish of tickers but things change... sometimes very quickly
The HL device will have a huge impact in reducing the length of hospital stays due to VAP and other respiratory illnesses as well as a number of benefits for its outpatient potential. Hint: when hospitals and insurance companies can save billions of dollars of the tech, especially when world...
Aytu BioPharma: Helping children get off to a healthier start and a better life.
Aytu is committed to improving the health of all children. We’re developing a portfolio of products to help children be their best and now expanding into ADHD. Our Adult and consumer health products remain an important part of our heritage, while we study COVID-19 treatments and...
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. The company markets Natesto, a nasal gel for the treatment of hypogonadism (low...
Descending wedge in the making. Shorts owned this ticker and showed an intraday head and shoulders yesterday (I took profits)
Bearish flow for now. Waiting for a retest of support and maybe a gap fill for another long position.
Gap at 4.80s Good luck.
AYTU has been under pressure forever with the 50 DMA being the strongest level of resistance over the last few months. However, if you take the chart waaayyyyy out, you'll see that it's bouncing off of a historic level of support, which was confirmed after this latest move. Yet again the 50DMA denied the rally even with higher volume. The company has an upcoming...
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. The company markets Natesto, a nasal gel for the treatment of hypogonadism (low...
This is for entertainment purposes only. I am not invested in this stock only indications of support and resistance.
The stock had a start up bullish approach but got rejected now back at a bearish sign.
Please not this is not financial advise just entertainment.
AYTU Bioscience Inc
(NASDAQ: $AYTU)
- Currently Sitting @ Bottom Of Purple Channel
- Bullish Cross-Over on MACD
- Bullish Divergence on RSI
- Low Market Cap (Under $150M)
#YouTube Video To Follow Shortly
